Hospital
Southern Baptist Hospital of Florida, INC
Southern Baptist Hospital of Florida, INC was paid $29.13M by Medicaid between Oct 2021 and Dec 2024, across 165 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoSOUTHERN BAPTIST HOSPITAL OF FLORIDA, INC
JACKSONVILLE, FL 32207
JACKSONVILLE, FL 32207
33aNPI1700553856assigned 08/26/2021
33bProvider typeChildren's Hospital
28Total paid$29.13M
24GClaims117,914
24DCodes billed165
24AFirst – last monthOct 2021 – Dec 2024
Compared with peers
Next to other Children's Hospital providers in Florida
Rank by total paid#3 of 6
Median peer was paid$668K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 10,772 | $1.51M | |
| 2022 | 4,472 | $150K | |
| 2023 | 62,165 | $15.63M | |
| 2024incomplete | 40,505 | $11.84M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 19,397 | 18,441 | $7.32M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 7,435 | 6,883 | $4.26M |
| 54161 | 8.7% | 961 | 902 | $2.55M | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.7% | 3,198 | 2,713 | $2.25M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 6.2% | 636 | 600 | $1.80M |
| G0378 | Hospital observation service, per hour | 6.2% | 6,256 | 3,904 | $1.80M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 4.8% | 775 | 723 | $1.41M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 4.2% | 1,794 | 1,669 | $1.22M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.0% | 3,140 | 1,067 | $1.17M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 4.0% | 1,950 | 1,809 | $1.17M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 1,604 | 1,544 | $439K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.4% | 1,948 | 1,840 | $415K |
153 more codes
| 93320 | 1.4% | 1,900 | $406K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 1.2% | 176 | $351K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.1% | 5,054 | $311K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,120 | $263K |
| 93325 | <1% | 2,116 | $174K | |
| 42830 | <1% | 47 | $152K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 61 | $97K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,840 | $86K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 214 | $83K |
| 97162 | <1% | 229 | $80K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 75 | $75K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,514 | $67K |
| 87631 | <1% | 458 | $67K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 82 | $66K |
| J2704 | Injection, propofol, 10 mg | <1% | 3,915 | $62K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,496 | $56K |
| 00920 | <1% | 1,310 | $54K | |
| 92526 | <1% | 289 | $53K | |
| 69610 | <1% | 12 | $51K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,847 | $46K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 1,727 | $42K |
| 80053 | Comprehensive metabolic panel | <1% | 2,949 | $40K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 209 | $36K |
| 93304 | <1% | 43 | $35K | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 990 | $34K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 375 | $34K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 193 | $33K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,232 | $31K |
| 86900 | <1% | 15 | $27K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 4,584 | $25K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 25 | $24K |
| 97161 | <1% | 86 | $22K | |
| 92523 | <1% | 90 | $20K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 356 | $18K |
| 76770 | <1% | 112 | $18K | |
| 87430 | <1% | 1,647 | $17K | |
| 97166 | <1% | 49 | $16K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,974 | $16K |
| 92610 | <1% | 46 | $15K | |
| 93321 | <1% | 64 | $14K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 991 | $14K |
| 49452 | <1% | 17 | $12K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 32 | $12K |
| 00635 | <1% | 13 | $11K | |
| 93975 | <1% | 23 | $8K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 187 | $8K |
| 87040 | <1% | 352 | $7K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 32 | $7K |
| 87088 | <1% | 845 | $7K | |
| 74240 | <1% | 47 | $7K | |
| 74019 | <1% | 510 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 463 | $6K |
| 97165 | <1% | 23 | $6K | |
| 87070 | <1% | 356 | $6K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 212 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 162 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,018 | $5K |
| 97755 | <1% | 13 | $4K | |
| 86140 | <1% | 541 | $4K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 417 | $4K |
| 81001 | <1% | 704 | $4K | |
| 97542 | <1% | 58 | $4K | |
| 84145 | <1% | 169 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 240 | $3K |
| 85027 | <1% | 321 | $2K | |
| 00126 | <1% | 218 | $2K | |
| 81002 | <1% | 247 | $2K | |
| 74018 | <1% | 143 | $2K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 379 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 74 | $2K |
| 87081 | <1% | 603 | $2K | |
| 96409 | <1% | 21 | $2K | |
| 72141 | <1% | 25 | $1K | |
| 74230 | <1% | 30 | $1K | |
| C1889 | Implantable/insertable device, not otherwise classified | <1% | 42 | $1K |
| 82248 | <1% | 37 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 27 | $1K |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | <1% | 118 | $908.04 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 210 | $859.99 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 257 | $809.56 |
| 96376 | <1% | 46 | $697.71 | |
| 00300 | <1% | 14 | $627.02 | |
| 73560 | <1% | 18 | $620.82 | |
| 81003 | <1% | 142 | $539.91 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 123 | $520.28 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 148 | $497.09 |
| 92587 | <1% | 19 | $475.26 | |
| 76010 | <1% | 14 | $396.33 | |
| 85652 | <1% | 327 | $363.82 | |
| A9573 | Injection, gadopiclenol, 1 ml | <1% | 15 | $281.92 |
| 73130 | <1% | 27 | $273.42 | |
| 85730 | <1% | 117 | $267.14 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 278 | $241.15 |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | <1% | 55 | $213.40 |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | $146.75 |
| 85007 | <1% | 312 | $144.69 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 60 | $144.69 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 102 | $101.28 |
| 84100 | <1% | 143 | $96.46 | |
| 81025 | <1% | 189 | $96.46 | |
| 85610 | <1% | 119 | $96.46 | |
| 83735 | <1% | 133 | $96.46 | |
| 87077 | <1% | 82 | $96.46 | |
| 73590 | <1% | 14 | $86.39 | |
| 80305 | <1% | 92 | $48.23 | |
| 87186 | <1% | 74 | $48.23 | |
| 76937 | <1% | 13 | $48.23 | |
| 71045 | Radiologic examination, chest; single view | <1% | 279 | $48.23 |
| 82962 | <1% | 130 | $48.23 | |
| 82550 | <1% | 30 | $48.23 | |
| 82150 | <1% | 78 | $48.23 | |
| 83690 | <1% | 173 | $48.23 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 117 | $48.23 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 24 | $48.23 |
| 89051 | 0% | 18 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 93 | $0.00 |
| 85046 | 0% | 64 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 121 | $0.00 |
| 87045 | 0% | 67 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 55 | $0.00 |
| 82247 | 0% | 13 | $0.00 | |
| 00840 | 0% | 13 | $0.00 | |
| L8613 | Ossicula implant | 0% | 59 | $0.00 |
| 00731 | 0% | 20 | $0.00 | |
| 69210 | 0% | 13 | $0.00 | |
| 84439 | 0% | 32 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 122 | $0.00 |
| 73610 | 0% | 14 | $0.00 | |
| 76376 | 0% | 20 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 28 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 15 | $0.00 |
| 93308 | 0% | 14 | $0.00 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 14 | $0.00 |
| J9370 | Vincristine sulfate, 1 mg | 0% | 19 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 199 | $0.00 |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 0% | 40 | $0.00 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 14 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 115 | $0.00 |
| 95700 | 0% | 61 | $0.00 | |
| 01922 | 0% | 19 | $0.00 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 32 | $0.00 |
| C1769 | Guide wire | 0% | 39 | $0.00 |
| 74022 | 0% | 56 | $0.00 | |
| B4088 | Gastrostomy/jejunostomy tube, low-profile, any material, any type, each | 0% | 18 | $0.00 |
| 86850 | 0% | 12 | $0.00 | |
| 73090 | 0% | 54 | $0.00 | |
| 84484 | 0% | 18 | $0.00 | |
| 88108 | 0% | 14 | $0.00 | |
| 87205 | 0% | 41 | $0.00 | |
| 83605 | 0% | 13 | $0.00 | |
| 00120 | 0% | 15 | $0.00 | |
| 83880 | 0% | 12 | $0.00 | |
| 86901 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHIGGINBOTHAM, SUSAN (DIRECTOR REVENUE CYCLE)
Parent organizationSOUTHERN BAPTIST HOSPITAL OF FLORIDA, INC